BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12527885)

  • 21. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATM activity contributes to the tumor-suppressing functions of p14ARF.
    Li Y; Wu D; Chen B; Ingram A; He L; Liu L; Zhu D; Kapoor A; Tang D
    Oncogene; 2004 Sep; 23(44):7355-65. PubMed ID: 15258567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of E2F-1 gene expression in avian cells.
    Espanel X; Le Cam L; North S; Sardet C; Brun G; Gillet G
    Oncogene; 1998 Aug; 17(5):585-94. PubMed ID: 9704924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JNK activation is regulated by E2F and promotes E2F1-induced apoptosis.
    Bashari D; Hacohen D; Ginsberg D
    Cell Signal; 2011 Jan; 23(1):65-70. PubMed ID: 20800677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the transcription factor DP in apoptosis.
    Hitchens MR; Robbins PD
    Apoptosis; 2003 Oct; 8(5):461-8. PubMed ID: 12975577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.
    Katich SC; Zerfass-Thome K; Hoffmann I
    Oncogene; 2001 Feb; 20(5):543-50. PubMed ID: 11313986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
    Nguyen DX; Westbrook TF; McCance DJ
    J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.
    Datta A; Sen J; Hagen J; Korgaonkar CK; Caffrey M; Quelle DE; Hughes DE; Ackerson TJ; Costa RH; Raychaudhuri P
    Mol Cell Biol; 2005 Sep; 25(18):8024-36. PubMed ID: 16135794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
    Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
    Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the Atm promoter in vivo.
    Gueven N; Fukao T; Luff J; Paterson C; Kay G; Kondo N; Lavin MF
    Genes Chromosomes Cancer; 2006 Jan; 45(1):61-71. PubMed ID: 16180236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation.
    Chen K; Albano A; Ho A; Keaney JF
    J Biol Chem; 2003 Oct; 278(41):39527-33. PubMed ID: 12890678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.
    Rogoff HA; Pickering MT; Debatis ME; Jones S; Kowalik TF
    Mol Cell Biol; 2002 Aug; 22(15):5308-18. PubMed ID: 12101227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
    Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
    Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis.
    Hong S; Paulson QX; Johnson DG
    Cell Cycle; 2008 Feb; 7(3):391-400. PubMed ID: 18235226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis.
    Hershko T; Ginsberg D
    J Biol Chem; 2004 Mar; 279(10):8627-34. PubMed ID: 14684737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways.
    Phillips AC; Ernst MK; Bates S; Rice NR; Vousden KH
    Mol Cell; 1999 Nov; 4(5):771-81. PubMed ID: 10619024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
    Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Komori H; Ohtani K
    Biochem Biophys Res Commun; 2014 Jul; 450(1):240-6. PubMed ID: 24893334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stable siRNA-mediated silencing of ATM alters the transcriptional profile of HeLa cells.
    Chen S; Wang G; Makrigiorgos GM; Price BD
    Biochem Biophys Res Commun; 2004 May; 317(4):1037-44. PubMed ID: 15094373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of retinoblastoma protein family function by human papillomavirus type 16 E7 oncoprotein inhibits lens development in part through E2F-1.
    McCaffrey J; Yamasaki L; Dyson NJ; Harlow E; Griep AE
    Mol Cell Biol; 1999 Sep; 19(9):6458-68. PubMed ID: 10454591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage.
    Ianari A; Gallo R; Palma M; Alesse E; Gulino A
    J Biol Chem; 2004 Jul; 279(29):30830-5. PubMed ID: 15123636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.